Home > Companies > Primary Health Care Corporation

Primary Health Care Corporation

phcc.qa

Welcome to the page of Primary Health Care Corporation. PHCC is dedicated to providing the people of Qatar with highest level of health care by operating and managing different Health Centers across the state of Qatar. Currently, the Primary Health Care Corporation is operating through 23 primary health care centers distributed into three regions, namely Central, Western, and Northern. Thirteen of these centers are located in Doha city, while the rest of centers are located in populated areas in all parts of the country in order to provide a wide variety of different types of health care services that depend on the location and needs of each area throughout a set of objectives which focuses on keeping the health of population, and prevention from diseases, in addition to patient Diagnose and treatment, and the provision of a long-term and constant support to patients and their families from infants to elderly, children, adults, married couples, and mothers.

C-Suite On Deck

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Events

National Medtech & Biotech Summit 2024

Conference

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference

Related News

Business Insights, PHARMACY MARKET

PCI PHARMA SERVICES EXPANDS BIOLOGICS LEADERSHIP WITH NEW CENTER OF EXCELLENCE FACILITY IN THE MIDWEST

PCI Pharma Services | March 20, 2023

PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), announced plans for a new 200,000-square-foot facility in Rockford, Illinois to enhance the organization’s capacity in injectable drug-device combination product assembly of both biologics and small molecules. Building on PCI’s leadership in this space with its Philadelphia Biotech Center of Excellence, the new facility is the second expansion building off the success i...

WOULD-BE CORONAVIRUS DRUGS ARE CHEAP TO MAKE

Science | April 10, 2020

With a vaccine for the novel coronavirus still likely a year or more away, the first weapon against the virus could be one of the drugs now in clinical trials with COVID-19 patients. A new analysis out today shows that many of these drugs, which are currently manufactured or in development to treat other diseases, can be made for $1 a day per patient, or less. If any prove effective against the novel coronavirus, a coordinated international effort will be needed to ensure they are made affordabl...

Pharma Tech

WCG ANNOUNCES PARTNERSHIP WITH MINT MEDICAL TO SUPPORT IMAGING IN ONCOLOGY CLINICAL TRIALS

PRNewswire | June 29, 2023

WCG, one of the world's leading providers of solutions that measurably improve the quality, efficiency, and safety of clinical research, recently announced a partnership with Mint Medical to leverage its mint Lesion™ radiology platform for oncology trials. The mint Lesion™ software is used for standardized and computer-assisted review of medical imaging according to defined protocols, guidelines, and workflows. Compliant and highly configurable, mint Lesion&trade...

Business Insights

ACULYS PHARMA AND SUSMED HAVE ENTERED INTO A CONTRACT TO CONDUCT THE WORLD'S FIRST CLINICAL TRIAL UTILIZING BLOCKCHAIN TECHNOLOGY

Aculys Pharma, Inc. | July 13, 2022

Aculys Pharma, Inc. a company focused on the development and commercialization of new innovative drugs in the fields of neurology and psychiatry, has entered into a contract with SUSMED, Inc., a company that promotes digital medicine to conduct the world's first1 corporate-sponsored clinical trial using blockchain technology. The clinical trial utilizing this blockchain technology, provided by SUSMED, will be conducted in collaboration with CMIC Co., Ltd., a pioneer in drug development suppo...

Business Insights, PHARMACY MARKET